{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-014642","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.142748+00:00","generated_at":"2026-05-23T10:15:49.364281+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Immunovant CEO Pete Salzmann retires; Eric Venker appointed; IMVT-1402 adds SjD and CLE indications","bullets":["Pete Salzmann retired as Immunovant CEO and Director; Eric Venker (Roivant President & COO) appointed CEO; Tiago Girao named CFO.","IND cleared for IMVT-1402 in Sjögren’s Disease; registrational study expected summer 2025.","Proof-of-concept study initiated for IMVT-1402 in Cutaneous Lupus Erythematosus (CLE).","Roivant to lead Immunovant investor relations; cash runway supports through Graves' Disease readout in 2027.","Robert Susman and Jacob Bauer join Immunovant Board; George Migausky steps down."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-014642","json":"https://secwatch.observer/filing/0001140361-25-014642.json","markdown":"https://secwatch.observer/filing/0001140361-25-014642.md","text":"https://secwatch.observer/filing/0001140361-25-014642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125014642/0001140361-25-014642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125014642/ef20047653_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:15:49.364281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}